The Commission assessed all the information provided by the applicant and considered that it has sufficiently substantiated the fulfilment of the requirements laid down in Article 26(2) of Regulation (EU) 2015/2283. Therefore, the compositional data, the stability data, the ileal digestion analysis, the proteomic analysis, the endophytic bacteria screening analyses, the bacterial reverse mutation test and the in vitro micronucleus test should be protected in accordance with Article 27(1) of Regulation (EU) 2015/2283. Accordingly, only the applicant should be authorised to place protein concentrate from Lemna gibba and Lemna minor on the market within the Union during a period of five years from the entry into force of this Regulation.
Recital 12, Regulation (EU) 2024/1048
In forcesince 9 Apr 2024